We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VPU
1076
Vanguard Utilities ETF
VPU
$8.44B
$6.41M 0.01%
48,203
+3,203
+7% +$419K
BTO
1077
John Hancock Financial Opportunities Fund
BTO
$803M
$6.38M 0.01%
198,235
-3,416
-2% -$111K
PWR icon
1078
Quanta Services
PWR
$101B
$6.38M 0.01%
166,955
+30,037
+22% +$1.14M
CBRL icon
1079
Cracker Barrel
CBRL
$1.29B
$6.37M 0.01%
37,301
-1,059
-3% -$173K
HYD icon
1080
VanEck High Yield Muni ETF
HYD
$4.4B
$6.36M 0.01%
99,710
+15,069
+18% +$951K
PPLI
1081
People Inc
PPLI
$3.1B
$6.33M 0.01%
162,955
+6,093
+4% +$243K
NBIX icon
1082
Neurocrine Biosciences
NBIX
$16.6B
$6.33M 0.01%
75,025
+17,853
+31% +$1.47M
LBRDA icon
1083
Liberty Broadband Class A
LBRDA
$5.16B
$6.33M 0.01%
61,577
-2,840
-4% -$279K
NUO
1084
DELISTED
Nuveen Ohio Quality Municipal Income Fund
NUO
$6.33M 0.01%
424,601
-71,408
-14% -$1.06M
MC icon
1085
Moelis & Co
MC
$4.94B
$6.31M 0.01%
180,604
-42,615
-19% -$1.54M
EOI
1086
Eaton Vance Enhanced Equity Income Fund
EOI
$826M
$6.3M 0.01%
420,852
+121,105
+40% +$1.78M
IMCG icon
1087
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.12B
$6.25M 0.01%
149,076
+15,162
+11% +$612K
PFM icon
1088
Invesco Dividend Achievers ETF
PFM
$808M
$6.25M 0.01%
217,876
-1,289
-0.6% -$36.2K
ENR icon
1089
Energizer
ENR
$1.55B
$6.24M 0.01%
161,463
-125
-0.1% -$5.59K
MELI icon
1090
Mercado Libre
MELI
$92.3B
$6.23M 0.01%
10,189
-3,358
-25% -$1.87M
FXD icon
1091
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
$6.23M 0.01%
145,533
-1,447
-1% -$61.8K
PKW icon
1092
Invesco BuyBack Achievers ETF
PKW
$1.76B
$6.22M 0.01%
99,426
-871
-0.9% -$53.7K
TEVA icon
1093
Teva Pharmaceuticals
TEVA
$41.2B
$6.18M 0.01%
670,115
+164,720
+33% +$1.99M
AXON
1094
Axon Enterprise
AXON
$46.4B
$6.16M 0.01%
96,004
+33,751
+54% +$2.2M
ZG icon
1095
Zillow
ZG
$7.63B
$6.16M 0.01%
134,541
+1,788
+1% +$70.2K
EFAD icon
1096
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$64.5M
$6.14M 0.01%
163,814
+27,225
+20% +$1.01M
CERS icon
1097
Cerus
CERS
$474M
$6.14M 0.01%
1,091,928
+105,398
+11% +$583K
WYNN icon
1098
Wynn Resorts
WYNN
$10.6B
$6.13M 0.01%
49,418
-6,276
-11% -$807K
LII icon
1099
Lennox International
LII
$15.2B
$6.13M 0.01%
22,271
+1,958
+10% +$534K
KWR icon
1100
Quaker Houghton
KWR
$2.92B
$6.12M 0.01%
30,158
-1,750
-5% -$356K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.